Designing optimal bioassays for measuring ADCC & ADCP activity

Increased interest in therapeutic monoclonal antibody (mAb) development has led to the need for sensitive, reliable, and biologically relevant bioassays for measuring Fc-effector activity. In this application note, Svar Life Science presents the advantages of using iLite Fc-effector activity bioassays for measuring ADCC and ADCP activity in vitro.